Active Ingredient History
Quizartinib, sold under the brand name Vanflyta, is an anti-cancer medication used for the treatment of acute myeloid leukemia. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Biomarkers (Phase 1/Phase 2)
Bone Marrow Cells (Phase 2)
Drug Interactions (Early Phase 1)
Drugs, Investigational (Early Phase 1)
Healthy Volunteers (Phase 1)
Leukemia (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 1/Phase 2)
Liver Diseases (Phase 1)
Mutation (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 1/Phase 2)
Neoplasms (Phase 1)
Pharmacokinetics (Early Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue